Pharmaceutical Drug Delivery Market to Hit USD 2,546 Billion by 2029 | MarketsandMarkets™
Comunicato Precedente
Comunicato Successivo
Browse in-depth TOC on "Pharmaceutical Drug Delivery Market"
907 - Tables
63 - Figures
718 - Pages
Injectable Drug Delivery Sector Leading the Market
Injectable drug delivery holds the largest market share among administration routes, primarily due to its effectiveness in managing chronic diseases. Injectables offer advantages over oral medications by improving patient adherence and reducing dosing frequency. Advances in injectable technologies, aimed at minimizing needle pain and complications, are further fueling growth in this segment.
Hospitals to Experience Rapid Market Expansion
The pharmaceutical drug delivery market is segmented by facility of use, including hospitals, ambulatory surgical centers, diagnostic centers, home care settings, and other facilities. Hospitals are projected to see the most substantial growth due to high patient traffic, increased need for various medications and delivery devices, a rise in surgeries, and a growing prevalence of chronic diseases, which are driving up hospital admissions and, consequently, the demand for drug delivery solutions.
Asia Pacific Region Poised for Significant Growth
The pharmaceutical drug delivery market is divided into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Asia Pacific is expected to register the highest growth rate in the coming years, driven by the presence of leading pharmaceutical companies, a growing patient population with chronic conditions, increased healthcare spending, and government efforts to enhance access to pharmaceutical treatments in the region.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=1085
Major Market Players and Their Strategies
Prominent players in the pharmaceutical drug delivery market include Johnson & Johnson Services, Inc. (US), Novartis AG (Switzerland), F. Hoffmann-La Roche Ltd (Switzerland), Pfizer Inc. (US), Becton, Dickinson and Company (US), GlaxoSmithKline plc (UK), Merck & Co., Inc. (US), Sanofi (France), Bayer AG (Germany), Amgen, Inc. (US), AbbVie Inc. (US), Genmab A/S (Denmark), Gilead Sciences, Inc. (US), Boehringer Ingelheim International GmbH (Germany), and AstraZeneca (UK).
Johnson & Johnson Services, Inc. Focuses on Innovation
Johnson & Johnson Services, Inc., a leading player in the pharmaceutical drug delivery market, offers a broad range of products across major therapeutic areas. The company emphasizes product innovation and R&D, with an annual R&D expenditure of approximately USD 15 million, accounting for 17.7% of its total revenue. Johnson & Johnson has a strong presence in North America, Europe, Asia Pacific, and Africa. To ensure continued growth, the company pursues partnerships, agreements, and mergers and acquisitions to expand its product portfolio and regional reach.
Novartis AG: A Key Market Leader
Novartis AG stands out in the pharmaceutical drug delivery market due to its extensive global presence and strong brand recognition. The company offers a comprehensive portfolio in therapeutic areas such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology. Novartis focuses on high-growth fields and prioritizes resource allocation to these areas. The company strengthens its business through strategic partnerships, collaborations, and agreements to enhance its operations and market position.
For more information, Inquire Now!
Related Reports:
Insulin Delivery Devices Market
Injectable Drug Delivery Market
Get access to the latest updates on Pharmaceutical Drug Delivery Companies and Pharmaceutical Drug Delivery Market Size
About MarketsandMarkets™:
MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com/
View original content:https://www.prnewswire.co.uk/news-releases/pharmaceutical-drug-delivery-market-to-hit-usd-2-546-billion-by-2029--marketsandmarkets-302248847.html
